[Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin]. [electronic resource]
- Archivos espanoles de urologia
- 35-40 p. digital
Publication Type: Clinical Trial; Comparative Study; English Abstract; Journal Article
0004-0614
Aged Aged, 80 and over Anemia--drug therapy Antineoplastic Agents--therapeutic use Epoetin Alfa Erythropoietin--adverse effects Hematinics--adverse effects Hemoglobins--analysis Humans Male Middle Aged Prospective Studies Prostatic Neoplasms--drug therapy Quality of Life Recombinant Proteins Treatment Outcome